Navigation Links
Researchers receive NIH grant to study predictors and outcomes of autoimmune lung disease
Date:2/23/2010

CINCINNATIResearchers at the University of Cincinnati (UC) Interstitial Lung Disease Center have received a grant from the National Heart, Lung and Blood Institute to study ways ILD first appears in certain patient groups with autoimmune diseases and how to more efficiently diagnose and treat it.

ILD is a group of diseases that affect the tissues of the lungs instead of the airways, like asthma and emphysema do. It causes scarring of the lungs, is more difficult to diagnosis and treat than other kinds of lung diseases and is often fatal.

Brent Kinder, MD, director of the ILD Center and UC Health pulmonologist, says the $715,000 K23 clinical research grant will be used to find ways for physicians to more accurately diagnose and manage ILD patients who first present with undifferentiated connective tissue disease.

This disease is a chronic inflammatory autoimmune disease that affects multiple organ systems but is not developed enough for physicians to easily recognize and categorize.

Autoimmune diseases occur when the body produces abnormal cells that turn on the body and attack major organs and tissues. Connective tissue diseases include lupus, scleroderma, polymyositis, vasculitis, rheumatoid arthritis and Sjogren's syndrome.

"This study will look at the clinical course of the disease in patients with autoimmune ILDusing biomarkers and medical recordsand will help physicians determine which treatments tend to be the most beneficial," he says. "This research focuses on associating patient and disease characteristics with the best outcomes."

Kinder says that although 30 to 40 percent of all ILD patients present with connective tissue disease, there is often a delay in diagnosis because of the nonspecific nature and varied time course in development of autoimmune diseases.

"If patients don't meet criteria neatly, their illness is often treated as idiopathic, or as having an unknown cause," he continues. "This can lead to a delayed diagnosis and allows further progression of the illness before appropriate treatment is applied. We hope to discover better ways of identifying specific groups of ILD patients who present with connective tissue diseases, find out why this occurs and raise awareness for rheumatologists and pulmonologists, whose patients may be at risk for developing ILD."


'/>"/>

Contact: Katie Pence
katie.pence@uc.edu
513-558-4561
University of Cincinnati Academic Health Center
Source:Eurekalert

Related medicine news :

1. Husbands hostile, anti-social behaviors increase wives symptoms of depression, researchers find
2. Penn researchers find genetic link to leukemias with an unknown origin
3. Researchers discover second protective role for tumor-suppressor
4. Researchers chart genomic map spanning over 2 dozen cancers
5. Researchers find biomarkers in saliva for detection of early-stage pancreatic cancer
6. Clemson researchers develop hands-free texting application
7. GUMC researchers say flower power may reduce resistance to breast cancer drug tamoxifen
8. Urine protein test might help diagnose kidney damage from lupus, UT Southwestern researchers find
9. Researchers create drug to keep tumor growth switched off
10. Researchers Who Discovered First Genes for Stuttering will Present Findings to the National Stuttering Association
11. Researchers discover new way to kill pediatric brain tumors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the American ... Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. ... including advance care planning, healthcare costs and patient and family engagement. , AIR ...
(Date:6/25/2016)... ... 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his ... David Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps ... in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set ... drug or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, ... traumatic event. , Trauma sufferers tend to feel a range of emotions, from depression, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, ... treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including robotic ... osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... proud to recognize Dr. Barry M. Weintraub as a prominent plastic surgeon and ... women in the world, and the most handsome men, look naturally attractive. Plastic ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... SYDNEY , June 26, 2016 One of ... , has announced the formation of a new biotechnology company, Noxopharm ... raise $6m in an IPO and to list on the ASX. ... drug candidate, NOX66, ready to enter a Phase 1 clinical study ... been designed to address one of the biggest problems facing cancer ...
(Date:6/26/2016)... June 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as ... Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) ... Daylight Time). As previously announced on May ... definitive merger agreement under which Jazz Pharmaceuticals has commenced ...
(Date:6/26/2016)... Ontario , June 27, 2016  VMS Rehab ... Company,s Board will take whatever measures required to build ... Company,s stock which is currently listed on the OTC ... Wexler, Company Chairman and CEO, "We are seeing an ... difficult to understand, not only by the Company, but ...
Breaking Medicine Technology: